Wilmington Savings Fund Society’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.02M Sell
76,923
-1,652
-2% -$133K 0.13% 122
2026
Q1
$6.81M Sell
78,575
-110
-0.1% -$10.5K 0.16% 108
2025
Q4
$7.56M Sell
78,685
-2,549
-3% -$248K 0.18% 103
2025
Q3
$7.74M Sell
81,234
-21,254
-21% -$1.95M 0.19% 102
2025
Q2
$8.93M Buy
102,488
+27,292
+36% +$2.31M 0.16% 112
2025
Q1
$6.76M Buy
75,196
+136
+0.2% +$12.2K 0.13% 141
2024
Q4
$6M Buy
75,060
+1,687
+2% +$146K 0.11% 157
2024
Q3
$6.61M Buy
73,373
+60,016
+449% +$5.05M 0.12% 149
2024
Q2
$1.05M Sell
13,357
-482
-3% -$39.5K 0.04% 200
2024
Q1
$1.21M Buy
+13,839
New +$1.18M 0.05% 197
2023
Q3
$880K Sell
11,228
-3,346
-23% -$280K 0.04% 209
2023
Q2
$1.28M Buy
14,574
+2,935
+25% +$253K 0.05% 191
2023
Q1
$938K Sell
11,639
-148
-1% -$12.1K 0.04% 207
2022
Q4
$916K Sell
11,787
-392
-3% -$31.8K 0.04% 218
2022
Q3
$983K Sell
12,179
-2,893
-19% -$260K 0.05% 201
2022
Q2
$1.35M Buy
15,072
+217
+1% +$22K 0.06% 187
2022
Q1
$1.65M Buy
14,855
+768
+5% +$81.1K 0.06% 184
2021
Q4
$1.46M Buy
14,087
+308
+2% +$35.7K 0.05% 201
2021
Q3
$1.73M Sell
13,779
-25
-0.2% -$3.24K 0.07% 185
2021
Q2
$1.71M Sell
13,804
-166
-1% -$20.8K 0.07% 190
2021
Q1
$1.65M Sell
13,970
-559
-4% -$65.5K 0.07% 183
2020
Q4
$1.7M Sell
14,529
-1,352
-9% -$149K 0.07% 180
2020
Q3
$1.65M Buy
15,881
+933
+6% +$93.7K 0.08% 176
2020
Q2
$1.37M Sell
14,948
-251
-2% -$24.1K 0.07% 186
2020
Q1
$1.37M Buy
15,199
+4,181
+38% +$445K 0.08% 171
2019
Q4
$1.25M Sell
11,018
-524
-5% -$57.5K 0.06% 171
2019
Q3
$1.25M Sell
11,542
-514
-4% -$53.6K 0.07% 168
2019
Q2
$1.17M Sell
12,056
-1,027
-8% -$93.8K 0.06% 174
2019
Q1
$1.19M Buy
13,083
+94
+0.7% +$8.41K 0.06% 174
2018
Q4
$1.18M Buy
12,989
+524
+4% +$49K 0.07% 175
2018
Q3
$1.23M Sell
12,465
-628
-5% -$58.1K 0.06% 184
2018
Q2
$1.12M Buy
13,093
+3,016
+30% +$252K 0.06% 187
2018
Q1
$808K Sell
10,077
-220
-2% -$18.1K 0.05% 212
2017
Q4
$832K Sell
10,297
-238
-2% -$19.1K 0.05% 216
2017
Q3
$820K Sell
10,535
-3,773
-26% -$313K 0.05% 216
2017
Q2
$1.27M Buy
14,308
+1,503
+12% +$127K 0.08% 196
2017
Q1
$1.03M Hold
12,805
0.06% 201
2016
Q4
$912K Hold
12,805
0.06% 204
2016
Q3
$1.11M Sell
12,805
-1,079
-8% -$94K 0.07% 197
2016
Q2
$1.21M Sell
13,884
-1,314
-9% -$106K 0.08% 194
2016
Q1
$1.14M Sell
15,198
-1,270
-8% -$95.7K 0.07% 203
2015
Q4
$1.27M Sell
16,468
-687
-4% -$51.7K 0.08% 195
2015
Q3
$1.15M Sell
17,155
-1,071
-6% -$78.9K 0.07% 199
2015
Q2
$1.35M Sell
18,226
-1,617
-8% -$124K 0.08% 196
2015
Q1
$1.55M Buy
19,843
+5,892
+42% +$447K 0.09% 187
2014
Q4
$1.01M Sell
13,951
-517
-4% -$35.9K 0.06% 215
2014
Q3
$896K Sell
14,468
-903
-6% -$57.4K 0.05% 230
2014
Q2
$980K Sell
15,371
-600
-4% -$36.4K 0.05% 231
2014
Q1
$983K Buy
15,971
+940
+6% +$54.8K 0.06% 230
2013
Q4
$863K Buy
15,031
+1,475
+11% +$83.6K 0.05% 242
2013
Q3
$722K Sell
13,556
-940
-6% -$50.6K 0.04% 248
2013
Q2
$747K Buy
+14,496
New +$717K 0.05% 242

Other funds holding MDT

Wilmington Savings Fund Society's MDT Position: Q2 2026 in Review

Wilmington Savings Fund Society reduced its Medtronic (MDT) stake by 2.1% in Q2 2026, selling an estimated $133K and leaving 76,923 shares worth $6.02M. The position accounts for 0.13% of the portfolio, ranked #122.

Wilmington Savings Fund Society first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.93M in Q2 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Wilmington Savings Fund Society held 76,923 shares of Medtronic worth $6.02M as of Q2 2026.
  • Wilmington Savings Fund Society sold 1,652 Medtronic shares in Q2 2026, an estimated $133K.
  • Medtronic made up 0.13% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #122 holding.
  • Wilmington Savings Fund Society first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Wilmington Savings Fund Society's Medtronic position peaked at $8.93M in Q2 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.